BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 38054300)

  • 1. Chemotherapy-induced ovarian damage and protective strategies.
    Zhao P; Guo C; Du H; Xiao Y; Su J; Wang X; Yeung WSB; Li G; Wang T
    Hum Fertil (Camb); 2023 Oct; 26(4):887-900. PubMed ID: 38054300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ovarian damage from chemotherapy and current approaches to its protection.
    Spears N; Lopes F; Stefansdottir A; Rossi V; De Felici M; Anderson RA; Klinger FG
    Hum Reprod Update; 2019 Nov; 25(6):673-693. PubMed ID: 31600388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ovarian Follicle Depletion Induced by Chemotherapy and the Investigational Stages of Potential Fertility-Protective Treatments-A Review.
    Hao X; Anastácio A; Liu K; Rodriguez-Wallberg KA
    Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31548505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapy-induced damage to ovary: mechanisms and clinical impact.
    Bedoschi G; Navarro PA; Oktay K
    Future Oncol; 2016 Oct; 12(20):2333-44. PubMed ID: 27402553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unraveling the mechanisms of chemotherapy-induced damage to human primordial follicle reserve: road to developing therapeutics for fertility preservation and reversing ovarian aging.
    Szymanska KJ; Tan X; Oktay K
    Mol Hum Reprod; 2020 Aug; 26(8):553-566. PubMed ID: 32514568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overactivation or Apoptosis: Which Mechanisms Affect Chemotherapy-Induced Ovarian Reserve Depletion?
    Kashi O; Meirow D
    Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of PUMA protects the ovarian reserve during DNA-damaging chemotherapy and preserves fertility.
    Nguyen QN; Zerafa N; Liew SH; Morgan FH; Strasser A; Scott CL; Findlay JK; Hickey M; Hutt KJ
    Cell Death Dis; 2018 May; 9(6):618. PubMed ID: 29795269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The PARP inhibitor, olaparib, depletes the ovarian reserve in mice: implications for fertility preservation.
    Winship AL; Griffiths M; Lliberos Requesens C; Sarma U; Phillips KA; Hutt KJ
    Hum Reprod; 2020 Aug; 35(8):1864-1874. PubMed ID: 32604417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cyto-protective effects of LH on ovarian reserve and female fertility during exposure to gonadotoxic alkylating agents in an adult mouse model.
    Del Castillo LM; Buigues A; Rossi V; Soriano MJ; Martinez J; De Felici M; Lamsira HK; Di Rella F; Klinger FG; Pellicer A; Herraiz S
    Hum Reprod; 2021 Aug; 36(9):2514-2528. PubMed ID: 34333622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GnRH agonist leuprolide acetate does not confer any protection against ovarian damage induced by chemotherapy and radiation in vitro.
    Bildik G; Akin N; Senbabaoglu F; Sahin GN; Karahuseyinoglu S; Ince U; Taskiran C; Selek U; Yakin K; Guzel Y; Ayhan C; Alper E; Cetiner M; Balaban B; Mandel NM; Esen T; Iwase A; Urman B; Oktem O
    Hum Reprod; 2015 Dec; 30(12):2912-25. PubMed ID: 26466909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of chemotherapy-induced ovarian damage: possible roles for hormonal and non-hormonal attenuating agents.
    Roness H; Kalich-Philosoph L; Meirow D
    Hum Reprod Update; 2014; 20(5):759-74. PubMed ID: 24833728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. THERAPY OF ENDOCRINE DISEASE: Novel protection and treatment strategies for chemotherapy-associated ovarian damage.
    Xiong J; Xue L; Li Y; Tang W; Chen D; Zhang J; Dai J; Zhou S; Lu Z; Wu M; Wang S
    Eur J Endocrinol; 2021 May; 184(5):R177-R192. PubMed ID: 33630753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel insights into the pathophysiology of chemotherapy-induced damage to the ovary.
    Bedoschi GM; Navarro PA; Oktay KH
    Panminerva Med; 2019 Mar; 61(1):68-75. PubMed ID: 29962184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. mTORC1/2 inhibition preserves ovarian function and fertility during genotoxic chemotherapy.
    Goldman KN; Chenette D; Arju R; Duncan FE; Keefe DL; Grifo JA; Schneider RJ
    Proc Natl Acad Sci U S A; 2017 Mar; 114(12):3186-3191. PubMed ID: 28270607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BRCA-related ATM-mediated DNA double-strand break repair and ovarian aging.
    Turan V; Oktay K
    Hum Reprod Update; 2020 Jan; 26(1):43-57. PubMed ID: 31822904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic Consideration in Chemotherapy-Induced Ovarian Damage and Fertility Preservation.
    Kim S; Lee S; Park HT; Song JY; Kim T
    Genes (Basel); 2021 Sep; 12(10):. PubMed ID: 34680919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxicity of chemotherapy and radiation on female reproduction.
    Meirow D; Biederman H; Anderson RA; Wallace WH
    Clin Obstet Gynecol; 2010 Dec; 53(4):727-39. PubMed ID: 21048440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can Some Anticancer Treatments Preserve the Ovarian Reserve?
    Vallet N; Boissel N; Elefant E; Chevillon F; Pasquer H; Calvo C; Dhedin N; Poirot C
    Oncologist; 2021 Jun; 26(6):492-503. PubMed ID: 33458904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do cancer therapies damage the uterus and compromise fertility?
    Griffiths MJ; Winship AL; Hutt KJ
    Hum Reprod Update; 2020 Feb; 26(2):161-173. PubMed ID: 31863097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of chemotherapy-induced ovarian damage.
    Roness H; Kashi O; Meirow D
    Fertil Steril; 2016 Jan; 105(1):20-9. PubMed ID: 26677788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.